Medical Treatments for Prostate CancerThere are many different medical treatments for prostate cancer that involve the clinical care of a healthcare professional. These treatments include expectant therapy, surgery, radiation therapy, hormone therapy, and chemotherapy. Expectant therapy is to carefully observe and monitor the prostate cancer. Because prostate cancer cells often spread very slowly, many older men who have the disease may not need more extensive treatment. However, expectant therapy usually includes routine physician examinations, including digital rectal exams and PSA tests. The different types of surgery for prostate cancer are radical prostatectomy - an open-surgery procedure in which the entire prostate gland and surrounding tissue are removed. Transurethral resection of the prostate (TURP) - surgery to remove part of the prostate gland that surrounds the urethra. Cryosurgery - this procedure involves killing the cancer cells by freezing them with a small metal tool placed in the tumor. Side effects of prostate cancer surgery include incontinence and impotence. Incontinence is the inability to control urine and may result in dribbling of urine, especially immediately after surgery. Normal control usually returns within weeks or months after surgery. Impotence is the inability to achieve an erection. For a month, or so, after surgery, most men are not able to get an erection. Eventually, approximately 40 to 60 percent of men will be able to get an erection sufficient for sexual intercourse, but without ejaculation of semen, since removal of the prostate gland prevents that process.Radiation therapy uses high energy rays to kill or shrink cancer cells, and to decrease their ability to divide. Radiation is often used to treat prostate cancer that is still confined to the prostate gland, or has spread only to nearby tissue. If the disease is advanced, radiation may be used to reduce the size of the tumor and to provide relief from symptoms. Possible side effects of radiation for prostate cancer may include diarrhea, with or without blood in the stool, and colitis, problems associated with urination, a degree of impotence (inability to get an erection), which may occur within two years of radiation therapy. The goal of hormone therapy is to lower the level of male hormones in the body, particularly testosterone. Hormone therapy does not cure the cancer, and is often used to treat persons whose cancer has spread or recurred after treatment. Produced mainly in the testicles, testosterone causes prostate cancer cells to grow. Thus, reduced testosterone levels can make the prostate cancer shrink and become less active. Most studies show that hormone therapy works better if it is started early. Chemotherapy is the use of powerful, anti-cancer medications to kill cancer cells.. Hospitalization may be needed to monitor treatment and chemotherapy's side effects. Common side effects of chemotherapy include: nausea and vomiting, hair loss, anemia, reduced ability of blood to clot, mouth sores, increased likelihood of developing infections, fatigue. Most side effects disappear once treatment is stopped. |
| prostate cancer death rate |
|
wwwhymortalitydropping The National Cancer Institute recently reported data showing that the prostate cancer death rate in the United States declined between 1990 and 1995. Statin Use Linked With Decreased Prostate Cancer Mortality Rates Urologists and researchers have postulated in recent years that statin medications could have an impact on the growth and progression of prostate cancer. NIH Press Release -Recent Trends in Prostate Cancer Incidence - 11 The prostate cancer death rate for white men began dropping in 1992 and for black men in 1994. The rate declined 6.3 percent overall from 1991 to 1995. Comparison of Prostate Cancer Mortality in Five Countries: France Age-specific rates for males over 40 years of age by year of death for prostate cancer in five countries, rates per 100 000. Prostate cancer incidence and mortality rates and trends in the National vital statistics data were used for prostate cancer mortality rates for both countries, and age-adjusted and age-specific incidence and mortality Combo Therapy Cuts Prostate Cancer Death Rates Study supports hormone therapy with radiation, finding no raised risk to heart. Combo Therapy Cuts Prostate Cancer Death Rates Latest News and Information On Prostate Problems. Symptoms, risks, treatments and other information on Prostate Problems. HealthDay Combo Therapy Cuts Prostate Cancer Death Rates It remains unclear why there might be a link between obesity and death rates from prostate cancer. National Prostate Cancer Coalition: Screening Works: Prostate Screening Works: Prostate Cancer Death Rate Drops to Lowest Mark Ever Prostate cancer death rates dropped 32.5 percent in 10 years, according to new Cancer Research UK : Trends in UK cancer mortality statistics The age-standardised mortality rate for prostate cancer peaked at 30 per 100000 males in the early 1990s and has now fallen by 16% to 25. (Figure 3.5). Cancer Research UK : UK Prostate Cancer mortality statistics In older men aged 85 and over, prostate cancer is the most common cause of all cancer deaths.The numbers of deaths and the death rates by age are shown in MedlinePlus: Obesity Linked to Prostate Cancer Death Rates It remains unclear why there might be a link between obesity and death rates from prostate cancer. It's possible that metabolism rates in heavy men might MedlinePlus: Combo Therapy Cuts Prostate Cancer Death Rates 3 (HealthDay News) -- New research suggests that a common but controversial treatment for prostate cancer reduces long-term death rates without greatly Early Prostate Cancer Screening May Reduce Mortality Rate Early screening of prostate cancer in asymptomatic men may reduce their risk of death from metastatic prostate cancer by as much as 35 per cent, Obesity Dramatically Increases Death Rate From Prostate Cancer Obese men who are diagnosed with prostate cancer have more than two-and-a-half times the risk of dying from the disease as compared to men of normal weight ACS :: Prostate Cancer Deaths Down; Possible Link To PSA Test The death rate from prostate cancer is at an all-time low for both white and black In 1995, the prostate cancer death rate for white men age 50-84 years Recent Trends in Mortality Rates for Four Major Cancers, by Sex Death rates for prostate cancer were more than twice as high for blacks than for whites (Table 1). Rates were lowest among APIs. Death rates decreased for |
| prostate cancer death rate |
|
prostate cancer cryosurgery laser vaporization prostate nerve prostatectomy radical sparing malignant neoplasm of the prostate |